Diabetes Mellitus, Type 2
Conditions
Brief summary
The T2D Profile study examines the longitudinal molecular profiles of newly diagnosed type 2 diabetes (T2D), before and during guideline-based diabetes treatment.
Detailed description
The study included a total of 3 visits: At baseline and after 1 and 3 months of diabetes treatment according to standard of care. Visits included clinical examinations, questionnaires and clinical chemistry. In addition, samples were collected at each visits for comprehensive molecular profiling including proteomics, genomics, transcriptomics, metabolomics, lipidomics, antibody profiling, mass cytometry and gene profiling of fecal microbiota.
Interventions
None listed
Sponsors
Göteborg University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Signed informed consent to participate in the study. * Age 50-65 years. * T2D diagnosis (fasting p-glucose ≥7.0 mmol/L or an oral glucose tolerance test 2 hour p-glucose ≥11.1 mmol/L \[or ≥12.2 mmol/L if measured capillary\] at two separate occasions).
Exclusion criteria
* Diabetes medication before study start. * Severe hyperglycemia requiring hospitalization or immediate insulin treatment, as judged by the investigator. * Presence of any clinically significant disease which, in the opinion of the investigator, may interfere with the subject´s ability to participate in the study. * Any major surgical procedure or trauma within 4 weeks of the first study visit.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Molecular profiles during diabetes treatment | 3 months | Protein profiles will be compared between diabetes and control and diabetes treatment |
Outcome results
None listed